Ana Cespedes
Direttore/Membro del Consiglio presso ARGENX SE
Patrimonio netto: 83 219 $ in data 31/05/2024
Profilo
Dr. Ana Cespedes is an Independent Non-Executive Director at argenx SE, a Chief Operating Officer at International AIDS Vaccine Initiative, Inc., a Member of Congreso de los Diputados, a Member at Living Mindfulness SL, a Member at London School of Economics & Political Science and a Member-Oncology Data of National Institutes of Health.
She is on the Board of Directors at argenx SE and University of Navarra.
Dr. Cespedes was previously employed as a Managing Director by Merck Healthcare Foundation, a Senior Vice President-Global Marketing & Strategy by Merck KGAA Unsponsored ADR Facility, a Head-Corporate Affairs by Merck SL, a Managing Director by Serono Iberia, and a Co-Founder by Spanish Women Leaders Life Science.
She received her undergraduate degree from Universidad Complutense de Madrid, an MBA from the University of Navarra and a doctorate degree from Universidad Complutense de Madrid.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
ARGEN-X SE
0.00% | 20/02/2024 | 225 ( 0.00% ) | 83 219 $ | 31/05/2024 |
Posizioni attive di Ana Cespedes
| Società | Posizione | Inizio |
|---|---|---|
| ARGENX SE | Direttore/Membro del Consiglio | 12/12/2022 |
International AIDS Vaccine Initiative, Inc.
 International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | Direttore operativo | - |
| London School of Economics & Political Science | Corporate Officer/Principal | - |
| Congreso de los Diputados | Corporate Officer/Principal | - |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - |
| University of Navarra | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Ana Cespedes
| Società | Posizione | Fine |
|---|---|---|
Merck SL
 Merck SL Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, Merck SL is a Spanish company that manufactures pharmaceutical products. The company is based in Madrid, Spain. The company was founded in 1949. The CEO is Laura González Molero. | Corporate Officer/Principal | - |
| Merck KGAA Unsponsored ADR Facility | Vendite & Marketing | - |
Formazione di Ana Cespedes
| Universidad Complutense de Madrid | Doctorate Degree |
| University of Navarra | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ARGENX SE | Health Technology |
| Aziende private | 5 |
|---|---|
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | Health Technology |
| Congreso de los Diputados | Government |
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Government |
| Merck KGAA Unsponsored ADR Facility | |
Merck SL
Merck SL Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, Merck SL is a Spanish company that manufactures pharmaceutical products. The company is based in Madrid, Spain. The company was founded in 1949. The CEO is Laura González Molero. | Health Technology |
- Borsa valori
- Insiders
- Ana Cespedes
